Intas Pharmaceuticals acquires Prothya Biosolutions

Acquisition

Buyer
Intas Pharmaceuticals

Target
Prothya Biosolutions

Seller
Shareholders Prothya Biosolutions

Advisory Teams
BofA Securities, Evercore

Deal Value
Undisclosed

Announcement Date
11 August 2025

See all details on DealMaker

Top